Gist:
This article has shined a spotlight on the 20 largest publicly traded cannabis companies and showed most are not worthwhile investments. Data presented show a wide variation in performance among companies in the sector. Sadly, only five companies have large enough profit margins before biological adjustments to cover their operating expenses and earn an operating income. At the same time, seven companies have operating expenses that exceed their total revenue. Given these poor results, it should come as no surprise that investor enthusiasm for the cannabis sector has waned.
No comments:
Post a Comment